Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F R Balkwill

Showing results (91-100 of 99) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 99 results.
Lancet (London, England)|June 30, 1990
Reconstitution of interleukin 2 with albumin for infusionD W Miles, C R Bird, M Wadhwa, et al.
International Journal of Cancer|March 15, 1994
Expression of tumour necrosis factor (TNF alpha) and its receptors in benign and malignant breast tissueD W Miles, L C Happerfield, M S Naylor, et al.
European Journal of Cancer & Clinical Oncology|June 1, 1987
Interferons in oncology: current status and future directionsJ F Smyth, F R Balkwill, F Cavalli, et al.
Cancer Research|November 1, 1984
Positive interactions between interferon and chemotherapy due to direct tumor action rather than effects on host drug-metabolizing enzymesF R Balkwill, S Mowshowitz, S S Seilman, et al.
British Journal of Cancer|January 1, 1996
An inbred colony of oncogene transgenic mice: diversity of tumours and potential as a therapeutic modelH Thomas, A M Hanby, R A Smith, et al.
British Journal of Cancer|May 1, 1993
Activity of type IV collagenases in benign and malignant breast diseaseB Davies, D W Miles, L C Happerfield, et al.
Hematological Oncology|March 1, 1995
Multiple myeloma: an immunoclinical study of disease and response to treatmentP W Thavasu, R K Ganjoo, S A Maidment, et al.
The Journal of Clinical Investigation|May 1, 1995
The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancerR P Negus, G W Stamp, M G Relf, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 8, 2008
A clinical study assessing the tolerability and biological effects of infliximab, a TNF-alpha inhibitor, in patients with advanced cancerE R Brown, K A Charles, S A Hoare, et al.
Pageof 10

Showing results (91-100 of 99) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 99 results.
Lancet (London, England)|June 30, 1990
Reconstitution of interleukin 2 with albumin for infusionD W Miles, C R Bird, M Wadhwa, et al.
International Journal of Cancer|March 15, 1994
Expression of tumour necrosis factor (TNF alpha) and its receptors in benign and malignant breast tissueD W Miles, L C Happerfield, M S Naylor, et al.
European Journal of Cancer & Clinical Oncology|June 1, 1987
Interferons in oncology: current status and future directionsJ F Smyth, F R Balkwill, F Cavalli, et al.
Cancer Research|November 1, 1984
Positive interactions between interferon and chemotherapy due to direct tumor action rather than effects on host drug-metabolizing enzymesF R Balkwill, S Mowshowitz, S S Seilman, et al.
British Journal of Cancer|January 1, 1996
An inbred colony of oncogene transgenic mice: diversity of tumours and potential as a therapeutic modelH Thomas, A M Hanby, R A Smith, et al.
British Journal of Cancer|May 1, 1993
Activity of type IV collagenases in benign and malignant breast diseaseB Davies, D W Miles, L C Happerfield, et al.
Hematological Oncology|March 1, 1995
Multiple myeloma: an immunoclinical study of disease and response to treatmentP W Thavasu, R K Ganjoo, S A Maidment, et al.
The Journal of Clinical Investigation|May 1, 1995
The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancerR P Negus, G W Stamp, M G Relf, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 8, 2008
A clinical study assessing the tolerability and biological effects of infliximab, a TNF-alpha inhibitor, in patients with advanced cancerE R Brown, K A Charles, S A Hoare, et al.
Pageof 10